Travelers Target price 2026 - Analyst rating & recommendation
Travelers Classifications & Recommendation
Travelers Price Target
| Target Price | $366.69 |
| Price | $374.62 |
| Deviation | 2.12% |
| Number of Estimates | 27 |
| 27 Analysts have issued a price target Travelers 2027 . The average Travelers target price is $366.69. This is 2.12% lower than the current stock price. The highest price target is $451.50 20.52% , the lowest is $163.95 56.23% . | |
| A rating was issued by 35 analysts: 9 Analysts recommend Travelers to buy, 21 to hold and 5 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Travelers stock has an average upside potential 2027 of 2.12% . Most analysts recommend the Travelers stock at Hold. |
Sales and Margin forecast 2026, 2027 to 2030
22 Analysts have issued a sales forecast Travelers 2026 . The average Travelers sales estimate is
This results in the following potential growth metrics:
2 Analysts have issued an Travelers EBITDA forecast 2026. The average Travelers EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
33 Travelers Analysts have issued a net profit forecast 2026. The average Travelers net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2030
33 Analysts have issued a Travelers forecast for earnings per share. The average Travelers EPS is
This results in the following potential growth metrics and future valuations:
Current Travelers Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Mizuho |
Neutral
➜
Neutral
|
Unchanged | Jul 24 2026 |
| BMO Capital |
Outperform
➜
Market Perform
|
Downgrade | Jul 21 2026 |
| Roth Capital |
Buy
➜
Buy
|
Unchanged | Jul 21 2026 |
| Morgan Stanley |
Underweight
➜
Underweight
|
Unchanged | Jul 21 2026 |
| Barclays |
Underweight
➜
Underweight
|
Unchanged | Jul 21 2026 |
| Evercore ISI Group |
In-Line
➜
In-Line
|
Unchanged | Jul 20 2026 |
| Citigroup |
Neutral
➜
Neutral
|
Unchanged | Jul 20 2026 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Mizuho:
Neutral
➜
Neutral
|
Jul 24 2026 |
|
Downgrade
BMO Capital:
Outperform
➜
Market Perform
|
Jul 21 2026 |
|
Unchanged
Roth Capital:
Buy
➜
Buy
|
Jul 21 2026 |
|
Unchanged
Morgan Stanley:
Underweight
➜
Underweight
|
Jul 21 2026 |
|
Unchanged
Barclays:
Underweight
➜
Underweight
|
Jul 21 2026 |
|
Unchanged
Evercore ISI Group:
In-Line
➜
In-Line
|
Jul 20 2026 |
|
Unchanged
Citigroup:
Neutral
➜
Neutral
|
Jul 20 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
